These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9868091)

  • 41. Physiological changes during hemodialysis in patients with intradialysis hypertension.
    Chou KJ; Lee PT; Chen CL; Chiou CW; Hsu CY; Chung HM; Liu CP; Fang HC
    Kidney Int; 2006 May; 69(10):1833-8. PubMed ID: 16691262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of correlation between renal vein renin and therapeutic effect of percutaneous renal artery stenting].
    Feng YQ; Zhou YL; Luo JF; Yu DQ; Chen JY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):997-1000. PubMed ID: 16864097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of hemoultrafiltration and hemodialysis on endothelin.
    Lin SY; Chen LQ; Wang YH; Zhou JH
    Chin Med J (Engl); 1991 Apr; 104(4):288-91. PubMed ID: 2065545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur.
    Onuoha GN; Alpar EK
    Neuropeptides; 2000 Apr; 34(2):116-20. PubMed ID: 10985928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Plasma calcitonin gene-related peptide (CGRP) level in patients with essential hypertension].
    Shi XY; Yang Y; Zhao YT
    Zhonghua Nei Ke Za Zhi; 1990 Oct; 29(10):616-8, 639. PubMed ID: 2150797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiological, cardiovascular and neuroendocrine changes in hypertensive patients during the hemodialysis session.
    Gutiérrez-Adrianzén OA; Moraes ME; Almeida AP; Lima JW; Marinho MF; Marques AL; Madeiro JP; Nepomuceno L; da Silva JM; Silva GB; Daher EF; Rodrigues Sobrinho CR
    J Hum Hypertens; 2015 Jun; 29(6):366-72. PubMed ID: 25339292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelin-1 plasma levels in hemodialysis treatment--the influence of type 2 diabetes.
    Liakopoulos V; Wurth P; Mertens PR; Eleftheriadis T; Kourti P; Voliotis G; Heintz B; Koukoulis GN; Stefanidis I
    Ren Fail; 2005; 27(5):515-22. PubMed ID: 16152988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function.
    Yamamoto Y; Higa T; Kitamura K; Tanaka K; Kangawa K; Matsuo H
    Clin Nephrol; 1987 Feb; 27(2):84-6. PubMed ID: 2951044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma atrial natriuretic factor and blood pressure drops during hemodialysis.
    Viron B; Dussaule JC; Roger V; Wolf JP; Ardaillou R; Mignon F
    Nephron; 1994; 68(3):301-7. PubMed ID: 7838252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.
    Czupryniak A; Kałuzyńska A; Nowicki M; Wiecek B; Bald E; Owczarek D
    Kidney Blood Press Res; 2005; 28(1):27-31. PubMed ID: 15452382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma adrenomedullin levels in patients on hemodialysis.
    Yamasaki H; Nagake Y; Akagi S; Sugimoto T; Ichikawa H; Makino H
    Nephron; 2001 Sep; 89(1):20-5. PubMed ID: 11528227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients.
    de Paula FM; Peixoto AJ; Pinto LV; Dorigo D; Patricio PJ; Santos SF
    Kidney Int; 2004 Sep; 66(3):1232-8. PubMed ID: 15327422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Source of plasma adrenomedullin in a patient with pheochromocytoma receiving hemodialysis.
    Nomura T; Yamasaki M; Satoh F; Nomura Y; Mimata H
    Int J Urol; 2006 Apr; 13(4):427-30. PubMed ID: 16734863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients].
    Witkowicz J; Kokot F; Irzyniec T; Chudek J; Ficek R
    Pol Arch Med Wewn; 1999 Sep; 102(3):763-71. PubMed ID: 10949883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of erytropoietin treatment and hemodialysis on the serum endothelin level and intraocular pressure of hemodialysis patients.
    Karadag R; Yagci R; Aydin B; Kanbay M; Erdurmus M; Keskin UC; Akcay A; Durmus M
    Int Ophthalmol; 2009 Oct; 29(5):385-8. PubMed ID: 18641921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Levels of endothelin and atrial natriuretic peptide (ANP) in plasma of patients with chronic renal failure treated by hemodialysis].
    Kowalska K; Grzeszczak W; Kowalski D
    Pol Arch Med Wewn; 1993 Nov; 90(5):334-41. PubMed ID: 8146034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of platelet cytosolic calcium in regulation of blood pressure in patients on chronic hemodialysis.
    Nakamura M; Suzuki H; Yamakawa H; Saruta T
    Nephron; 1992; 61(4):435-41. PubMed ID: 1501742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical and experimental study on jiangzhi tiaoya granule in treating essential hypertension and protecting function of vascular endothelium].
    Jiang W; Zhang WG; Ma XS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jan; 22(1):18-20. PubMed ID: 12585164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
    Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
    Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure.
    Ishihara T; Yokota N; Hisanaga S; Fujimoto S; Hirayama N; Kato J; Kitamura K; Eto T
    Clin Nephrol; 1999 Aug; 52(2):119-23. PubMed ID: 10480223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.